Cited by 2,763Receptor Mechanisms and SignalingNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 404 of the 409 references it cites were found in a registry or an index.

The Physiology, Signaling, and Pharmacology of Dopamine Receptors

Beaulieu, Jean-Martin, Gainetdinov, Raul R.·2011·Pharmacological Reviews

DOI 10.1124/pr.110.002642

Open this paper in CoChat — free account

Abstract

G protein-coupled dopamine receptors (D1, D2, D3, D4, and D5) mediate all of the physiological functions of the catecholaminergic neurotransmitter dopamine, ranging from voluntary movement and reward to hormonal regulation and hypertension. Pharmacological agents targeting dopaminergic neurotransmission have been clinically used in the management of several neurological and psychiatric disorders, including Parkinson's disease, schizophrenia, bipolar disorder, Huntington's disease, attention deficit hyperactivity disorder (ADHD(1)), and Tourette's syndrome. Numerous advances have occurred in understanding the general structural, biochemical, and functional properties of dopamine receptors that have led to the development of multiple pharmacologically active compounds that directly target dopamine receptors, such as antiparkinson drugs and antipsychotics. Recent progress in understanding the complex biology of dopamine receptor-related signal transduction mechanisms has revealed that, in addition to their primary action on cAMP-mediated signaling, dopamine receptors can act through diverse signaling mechanisms that involve alternative G protein coupling or through G protein-independent mechanisms via interactions with ion channels or proteins that are characteristically implicated in receptor desensitization, such as β-arrestins. One of the future directions in managing dopamine-related pathologic conditions may involve a transition from the approaches that directly affect receptor function to a precise targeting of postreceptor intracellular signaling modalities either directly or through ligand-biased signaling pharmacology. In this comprehensive review, we discuss dopamine receptor classification, their basic structural and genetic organization, their distribution and functions in the brain and the periphery, and their regulation and signal transduction mechanisms. In addition, we discuss the abnormalities of dopamine receptor expression, function, and signaling that are documented in human disorders and the current pharmacology and emerging trends in the development of novel therapeutic agents that act at dopamine receptors and/or on related signaling events.

Integrity signals

Registry

Crossref · 10.1124/pr.110.002642

Cites

404 of 404 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Neurocircuitry of Addiction
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS.
Dahlstroem, A., & Fuxé, K. (1964) · PubMed · Cited by 5,133
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,756
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Seven-transmembrane receptors
Pierce, K. L., Premont, R. T., & Lefkowitz, R. J. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm908 · Cited by 2,712
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
Hyman, S. E., Malenka, R. C., & Nestler, E. J. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.113009 · Cited by 2,647
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
Sokoloff, P., Bruno Giros, A., Martres, M., Bouthenet, M.-L., & Schwartz, J. (1990) · Nature · doi:10.1038/347146a0 · Cited by 2,608
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220

Show all 409 references

Sorted by citations

Items 301–400 of 1,006

2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts
Newman, A. H., Battiti, F. O., & Bonifazi, A. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01105 · Cited by 79
Dopamine and Huntington’s disease
Schwab, L. C., Garas, S. N., Drouin‐Ouellet, J., Mason, S., Stott, S., & Barker, R. A. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1025383 · Cited by 79
In vivo evidence of neurophysiological maturation of the human adolescent striatum
Larsen, B., & Luna, B. (2015) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2014.12.003 · Cited by 78
Heritability of the affective response to exercise and its correlation to exercise behavior
Schutte, N. M., Nederend, I., Hudziak, J. J., Bartels, M., & de Geus, E. J. C. (2016) · Psychology of sport and exercise · doi:10.1016/j.psychsport.2016.12.001 · Cited by 78
Dopamine receptors in emesis: Molecular mechanisms and potential therapeutic function
Belkacemi, L., & Darmani, N. A. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105124 · Cited by 78
Dopamine and serotonin regulate tumor behavior by affecting angiogenesis
Peters, M. A. M., Walenkamp, A., Kema, I. P., Meijer, C., de Vries, E. G. E., & Oosting, S. F. (2014) · Drug Resistance Updates · doi:10.1016/j.drup.2014.09.001 · Cited by 78
Neurotransmission systems in Parkinson’s disease
Moghaddam, H. S., Zare-Shahabadi, A., Rahmani, F., & Rezaei, N. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0068 · Cited by 78
HIV, Tat and dopamine transmission
Gaskill, P. J., Miller, D. R., Gamble‐George, J., Yano, H., & Khoshbouei, H. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.04.015 · Cited by 78
Gi/o protein-coupled receptors in dopamine neurons inhibit the sodium leak channel NALCN
Philippart, F., & Khaliq, Z. M. (2018) · eLife · doi:10.7554/elife.40984 · Cited by 78
Unraveling the dynamics of dopamine release and its actions on target cells
Sippy, T., & Tritsch, N. X. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2022.12.005 · Cited by 77
Molecular and cellular mechanisms of dopamine-mediated behavioral plasticity in the striatum
Cerovic, M., d’Isa, R., Tonini, R., & Brambilla, R. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.06.013 · Cited by 77
Drug Induced Increases in CNS Dopamine Alter Monocyte, Macrophage and T Cell Functions: Implications for HAND
Gaskill, P. J., Calderon, T. M., Coley, J. S., & Berman, J. W. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9443-y · Cited by 77
Arrestin recruitment to dopamine D2 receptor mediates locomotion but not incentive motivation
Donthamsetti, P., Gallo, E. F., Buck, D. C., Stahl, E. L., Zhu, Y., Lane, J. R., Bohn, L., Neve, K. A., Kellendonk, C., & Javitch, J. A. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0212-4 · Cited by 77
Leukocyte telomere length in patients with schizophrenia: A meta-analysis
Polho, G. B., de Paula, V. D. J. R., Cardillo, G. D. M., dos Santos, B., & Kerr, D. S. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.04.025 · Cited by 76
Homology Modeling of Dopamine D2 and D3 Receptors: Molecular Dynamics Refinement and Docking Evaluation
Platania, C. B. M., Salomone, S., Leggio, G. M., Drago, F., & Bucolo, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044316 · Cited by 76
Functional selectivity of GPCR signaling in animals
Zhou, L., & Bohn, L. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.11.010 · Cited by 76
Doped overoxidized polypyrrole microelectrodes as sensors for the detection of dopamine released from cell populations
Sasso, L., Heiskanen, A. R., Diazzi, F., Dimaki, M., Castillo-León, J., Vergani, M., Landini, E., Raiteri, R., Ferrari, G., Carminati, M., et al. (2013) · The Analyst · doi:10.1039/c3an00085k · Cited by 76
Neural Inhibition of Dopaminergic Signaling Enhances Immunity in a Cell-Non-autonomous Manner
Cao, X., & Aballay, A. (2016) · Current Biology · doi:10.1016/j.cub.2016.06.036 · Cited by 76
Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases
Giovanni, G. D., Štrac, D. Š., Solé, M., Unzeta, M., Tipton, K. F., Mück‐Šeler, D., Bolea, I., Corte, L., Perković, M. N., Pivac, N., et al. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00541 · Cited by 76
Renal dopaminergic system: Pathophysiological implications and clinical perspectives
Choi, M. R. (2015) · World Journal of Nephrology · doi:10.5527/wjn.v4.i2.196 · Cited by 75
Role of dopamine in distal retina
Popova, E. (2014) · Journal of Comparative Physiology A · doi:10.1007/s00359-014-0906-2 · Cited by 75
Repurposing of Prochlorperazine for Use Against Dengue Virus Infection
Simanjuntak, Y., Liang, J., Lee, Y.-L., & Lin, Y. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu377 · Cited by 75
DTI and Myelin Plasticity in Bipolar Disorder: Integrating Neuroimaging and Neuropathological Findings
Bellani, M., Boschello, F., Delvecchio, G., Dusi, N., Altamura, C. A., Ruggeri, M., & Brambilla, P. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00021 · Cited by 75
The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson’s Disease
Mackie, P. M., Lebowitz, J., Saadatpour, L., Nickoloff, E., Gaskill, P. J., & Khoshbouei, H. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.03.020 · Cited by 75
Neuroinflammation and glial cell activation in mental disorders
Almeida, P. G. C., Nani, J. V. S., Oses, J. P., Brietzke, E. M., & Hayashi, M. A. F. (2019) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2019.100034 · Cited by 75
Basal ganglia for beginners: the basic concepts you need to know and their role in movement control
Rocha, G. S., Freire, M. A. M., de Britto, A. M., de Paiva, K. M., Oliveira, R. F., Fonseca, I. A. T., de Araújo, D. P., de Oliveira, L. C., Gúzen, F. P., Morais, P. L. A. D. G., et al. (2023) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2023.1242929 · Cited by 76
Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse model
Squitieri, F., Pardo, A. D., Favellato, Μ., Amico, E., Maglione, V., & Frati, L. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12604 · Cited by 74
Dopamine, cognitive function, and gamma oscillations: role of D4 receptors
Furth, K. E., Mastwal, S. S., Wang, K. H., Buonanno, A., & Vullhorst, D. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00102 · Cited by 74
Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia
Oda, Y., Kanahara, N., & Iyo, M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226228 · Cited by 74
A Survey of Biological Building Blocks for Synthetic Molecular Communication Systems
Söldner, C. A., Socher, E., Jamali, V., Wicke, W., Ahmadzadeh, A., Breitinger, H., Burkovski, A., Castiglione, K., Schober, R., & Sticht, H. (2020) · IEEE Communications Surveys & Tutorials · doi:10.1109/comst.2020.3008819 · Cited by 74
Porous boron doped diamond for dopamine sensing: Effect of boron doping level on morphology and electrochemical performance
Baluchová, S., Taylor, A., Mortet, V., Sedláková, S., Klimša, L., Kopeček, J., Hák, O., & Schwarzová‐Pecková, K. (2019) · Electrochimica Acta · doi:10.1016/j.electacta.2019.135025 · Cited by 74
Methamphetamine abuse disturbs the dopaminergic system to impair hippocampal-based learning and memory: An overview of animal and human investigations
Shukla, M., & Vincent, B. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.016 · Cited by 73
Effects of fluoxetine on fish: What do we know and where should we focus our efforts in the future?
Correia, D., Domingues, I., Faria, M., & Oliveira, M. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.159486 · Cited by 73
Locomotion activates PKA through dopamine and adenosine in striatal neurons
Ma, L., Day‐Cooney, J., Jáidar, O., Muniak, M. A., Qin, M., Ding, J., Mao, T., & Zhong, H. (2022) · Nature · doi:10.1038/s41586-022-05407-4 · Cited by 73
Phaeochromocytoma: a catecholamine and oxidative stress disorder
Pacák, K. (2011) · Endocrine Regulations · doi:10.4149/endo_2011_02_65 · Cited by 73
Dysfunctional dopaminergic neurotransmission in asocial BTBR mice
Squillace, M., Dodero, L., Federici, M., Migliarini, S., Errico, F., Napolitano, F., Krashia, P., Maio, A. D., Galbusera, A., Bifone, A., et al. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.69 · Cited by 73
Astrocytes in cocaine addiction and beyond
Wang, J., Holt, L. M., Huang, H. H., Sesack, S. R., Nestler, E. J., & Dong, Y. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01080-7 · Cited by 73
Post-transcriptional regulation of SHANK3 expression by microRNAs related to multiple neuropsychiatric disorders
Choi, S., Pang, K., Kim, J. Y., Ryu, J. R., Kang, H., Liu, Z., Kim, W.-K., Sun, W., Kim, H., & Han, K. (2015) · Molecular Brain · doi:10.1186/s13041-015-0165-3 · Cited by 72
The PI3K signaling pathway as a pharmacological target in Autism related disorders and Schizophrenia
Enríquez-Barreto, L., & Morales, M. (2016) · Journal of Green Engineering · doi:10.1186/s40591-016-0047-9 · Cited by 73
Dopaminergic and serotonergic mechanisms in the modulation of pain: In vivo studies in human brain
Martikainen, I. K., Hagelberg, N. M., Jääskeläinen, S. K., Hietala, J. A., & Pertovaara, A. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.07.038 · Cited by 72
Pharmacological management of ocular hypertension: current approaches and future prospective
Bucolo, C., Salomone, S., Drago, F., Reibaldi, M., Longo, A., & Uva, M. G. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.09.012 · Cited by 71
Dopamine modulation of sensory processing and adaptive behavior in flies
Siju, K. P., Backer, J. D., & Kadow, I. C. G. (2021) · Cell and Tissue Research · doi:10.1007/s00441-020-03371-x · Cited by 69
The fat mass and obesity-associated (FTO) gene: Obesity and beyond?
Hess, M. E., & Brüning, J. C. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.01.017 · Cited by 71
Molecular and cellular mechanisms underlying anti-neuronal antibody mediated disorders of the central nervous system
van Coevorden‐Hameete, M. H., de Graaff, E., Titulaer, M. J., Hoogenraad, C. C., & Smitt, P. A. E. S. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.10.016 · Cited by 71
Acupuncture Attenuated Vascular Dementia–Induced Hippocampal Long-Term Potentiation Impairments via Activation of D1/D5 Receptors
Yang, Y., Li, H., Yang, J., Wang, X., Shi, G., Yan, C.-Q., Ma, S., Zhu, W. X., Li, Q., Li, T.-R., et al. (2017) · Stroke · doi:10.1161/strokeaha.116.014696 · Cited by 71
Clarifying the Ghrelin System’s Ability to Regulate Feeding Behaviours Despite Enigmatic Spatial Separation of the GHSR and Its Endogenous Ligand
Edwards, A., & Abizaid, A. B. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040859 · Cited by 71
Novel Strategies To Activate the Dopamine D 1 Receptor: Recent Advances in Orthosteric Agonism and Positive Allosteric Modulation
Hall, A., Provins, L., & Valade, A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01767 · Cited by 71
Targeting the Dopaminergic System in Autoimmunity
Vidal, P. M., & Pacheco, R. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09834-5 · Cited by 71
Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects
Rampino, A., Marakhovskaia, A., Soares-Silva, T., Torretta, S., Veneziani, F., & Beaulieu, J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00702 · Cited by 72
Self-citation
Defective Trafficking of Rhodopsin and Its Role in Retinal Degenerations
Hollingsworth, T., & Gross, A. K. (2012) · International review of cytology · doi:10.1016/b978-0-12-394304-0.00006-3 · Cited by 71
Pharmacological animal models of Tourette syndrome
Bronfeld, M., Israelashvili, M., & Bar‐Gad, I. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.09.010 · Cited by 70
Circulating Triglycerides Gate Dopamine-Associated Behaviors through DRD2-Expressing Neurons
Berland, C., Montalban, E., Perrin, E., Miceli, M. D., Nakamura, Y., Martinat, M., Sullivan, M., Davis, X. S., Shenasa, M. A., Martin, C., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.02.010 · Cited by 70
Pathogenesis and Prevention of Worsening Axial Elongation in Pathological Myopia
Pugazhendhi, S., Ambati, B. K., & Hunter, A. A. (2020) · Clinical ophthalmology · doi:10.2147/opth.s241435 · Cited by 70
Salvianolic acid A relieves cognitive disorder after chronic cerebral ischemia: Involvement of Drd2/Cryab/NF-κB pathway
Yang, Y., Song, J., Liu, N., Wei, G., Liu, S., Zhang, S., Jiang, N., Yang, H., & Du, G. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105989 · Cited by 70
Expression of Dopaminergic Receptors on Human CD4+ T Lymphocytes: Flow Cytometric Analysis of Naive and Memory Subsets and Relevance for the Neuroimmunology of Neurodegenerative Disease
Kuštrimović, N. Z., Rasini, E., Legnaro, M., Marino, F., & Cosentino, M. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9541-5 · Cited by 70
Dopamine Increases CD14+CD16+ Monocyte Migration and Adhesion in the Context of Substance Abuse and HIV Neuropathogenesis
Coley, J. S., Calderon, T. M., Gaskill, P. J., Eugenin, E. A., & Berman, J. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117450 · Cited by 70
Striatal dopaminergic dysfunction at rest and during task performance in writer’s cramp
Berman, B. D., Hallett, M., Herscovitch, P., & Simonyan, K. (2013) · Brain · doi:10.1093/brain/awt282 · Cited by 70
Autoimmunity against dopamine receptors in neuropsychiatric and movement disorders: a review of Sydenham chorea and beyond
Cunningham, M. W., & Cox, C. J. (2015) · Acta Physiologica · doi:10.1111/apha.12614 · Cited by 71
Neural basis of reward anticipation and its genetic determinants
Jia, T., Macare, C., Desrivières, S., Gonzalez, D. A., Tao, C., Ji, X., Ruggeri, B., Nees, F., Banaschewski, T., Barker, G. J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503252113 · Cited by 70
Electrochemical dopamine sensor based on bi-metallic Co/Zn porphyrin metal–organic framework
Ma, J., Bai, W., Liu, X., & Zheng, J. (2021) · Microchimica Acta · doi:10.1007/s00604-021-05122-3 · Cited by 69
A peptide targeting an interaction interface disrupts the dopamine D1‐D2 receptor heteromer to block signaling and function in vitro and in vivo: effective selective antagonism
Hasbi, A., Perreault, M. L., Shen, M. Y. F., Zhang, L., To, R., Fan, T., Nguyen, T., Ji, X., O’Dowd, B. F., & George, S. R. (2014) · The FASEB Journal · doi:10.1096/fj.14-254037 · Cited by 69
Polypharmacology of dopamine receptor ligands
Butini, S., Nikolic, K. M., Kassel, S., Brückmann, H., Filipić, S., Agbaba, D. D., Gemma, S., Brogi, S., Brindisi, M., Campiani, G., et al. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.03.011 · Cited by 69
Activation of Dopamine D1-D2 Receptor Complex Attenuates Cocaine Reward and Reinstatement of Cocaine-Seeking through Inhibition of DARPP-32, ERK, and ΔFosB
Hasbi, A., Perreault, M. L., Shen, M. Y. F., Fan, T., Nguyen, T., Alijaniaram, M., Banasikowski, T. J., Grace, A. A., O’Dowd, B. F., Fletcher, P. J., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00924 · Cited by 70
Serotonin and dopamine modulate aging in response to food odor and availability
Miller, H. A., Huang, S., Dean, E. S., Schaller, M. L., Tuckowski, A. M., Munneke, A. S., Beydoun, S., Pletcher, S. D., & Leiser, S. F. (2022) · Nature Communications · doi:10.1038/s41467-022-30869-5 · Cited by 68
Dopamine receptor D2 confers colonization resistance via microbial metabolites
Scott, S. A., Fu, J., & Chang, P. V. (2024) · Nature · doi:10.1038/s41586-024-07179-5 · Cited by 68
Dopamine Promotes Motor Cortex Plasticity and Motor Skill Learning via PLC Activation
Rioult-Pedotti, M.-S., Pekanovic, A., Atiemo, C. O., Marshall, J. J., & Luft, A. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124986 · Cited by 68
Identification of G Protein-Biased Agonists That Fail To Recruit β-Arrestin or Promote Internalization of the D1 Dopamine Receptor
Conroy, J., Free, R. B., & Sibley, D. R. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00020 · Cited by 67
Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction?
Johnson, K. A., & Lovinger, D. M. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00264 · Cited by 67
Electrochemical reactions of catechol, methylcatechol and dopamine at tetrahedral amorphous carbon (ta-C) thin film electrodes
Palomäki, T., Chumillas, S., Sainio, S., Protopopova, V. S., Kauppila, M., Koskinen, J., Climent, V., Feliu, J. M., & Laurila, T. T. (2015) · Diamond and Related Materials · doi:10.1016/j.diamond.2015.09.003 · Cited by 66
Imaging Agonist-Induced D2/D3 Receptor Desensitization and Internalization In Vivo with PET/fMRI
Sander, C. Y. M., Hooker, J. M., Catana, C., Rosen, B. R., & Mandeville, J. B. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.296 · Cited by 66
Effects of an Environmentally Relevant PFAS Mixture on Dopamine and Steroid Hormone Levels in Exposed Mice
Grønnestad, R., Johanson, S. M., Müller, M. H. B., Schlenk, D., Tanabe, P., Krøkje, Å., Jaspers, V. L. B., Jenssen, B. M., Ræder, E. M., Lyche, J. L., et al. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115670 · Cited by 65
Bacteroides uniformis CECT 7771 Modulates the Brain Reward Response to Reduce Binge Eating and Anxiety-Like Behavior in Rat
Agustí, A., Campillo, I., Balzano, T., Benítez‐Páez, A., López‐Almela, I., Romaní‐Pérez, M., Forteza, J., Felipo, V., Avena, N. M., & Sanz, Y. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02462-2 · Cited by 65
Inhibition of glycogen synthase kinase 3 by lithium, a mechanism in search of specificity
Chatterjee, D., & Beaulieu, J. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1028963 · Cited by 65
Self-citation
Japanese Encephalitis Virus Exploits Dopamine D2 Receptor-phospholipase C to Target Dopaminergic Human Neuronal Cells
Simanjuntak, Y., Liang, J., Lee, Y.-L., & Lin, Y. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00651 · Cited by 65
Dopaminergic Signaling in the Nucleus Accumbens Modulates Stress-Coping Strategies during Inescapable Stress
Cui, W., Aida, T., Ito, H., Kobayashi, K., Wada, Y., Kato, S., Nakano, T., Zhu, M., Isa, K., Kobayashi, K., et al. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0444-20.2020 · Cited by 64
Repurposing the Antipsychotic Trifluoperazine as an Antimetastasis Agent
Pulkoski‐Gross, A., Li, J., Zheng, C. J., Li, Y., Ouyang, N., Rigas, B., Zucker, S., & Cao, J. P. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.096941 · Cited by 64
Dopamine D2 Receptor Antagonism Suppresses Tau Aggregation and Neurotoxicity
McCormick, A. V., Wheeler, J. M., Guthrie, C. R., Liachko, N. F., & Kraemer, B. C. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.08.027 · Cited by 64
Fluoxetine modulates the transcription of genes involved in serotonin, dopamine and adrenergic signalling in zebrafish embryos
Cunha, V. F. P. M., Rodrigues, P., Santos, M. M., Moradas-Ferreira, P., & Ferreira, M. (2017) · Chemosphere · doi:10.1016/j.chemosphere.2017.10.100 · Cited by 64
Siloxene, Germanane, and Methylgermanane: Functionalized 2D Materials of Group 14 for Electrochemical Applications
Rosli, N. F., Rohaizad, N., Šturala, J., Fisher, A. C., Webster, R. D., & Pumera, M. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910186 · Cited by 64
Sympathoadrenergic modulation of hematopoiesis: a review of available evidence and of therapeutic perspectives
Cosentino, M., Marino, F., & Maestroni, G. J. M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00302 · Cited by 63
The Dopamine Receptor D3 Regulates Lipopolysaccharide-Induced Depressive-Like Behavior in Mice
Wang, J., Jia, Y., Li, G., Wang, B., Zhou, T., Zhu, L., Chen, T., & Chen, Y. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy005 · Cited by 63
Ligand recognition and biased agonism of the D1 dopamine receptor
Teng, X., Chen, S., Nie, Y., Xiao, P., Yu, X., Shao, Z., & Zheng, S. (2022) · Nature Communications · doi:10.1038/s41467-022-30929-w · Cited by 63
Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression?
Zhao, F., Cheng, Z., Piao, J., Cui, R., & Li, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.947785 · Cited by 64
Target-Specific Suppression of GABA Release from Parvalbumin Interneurons in the Basolateral Amygdala by Dopamine
Chu, H., Ito, W., Li, J., & Morozov, A. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2997-12.2012 · Cited by 63
The effect of metformin on prolactin levels in patients with drug-induced hyperprolactinemia
Krysiak, R. G., Kowalcze, K. E., Szkróbka, W., & Okopień, B. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.01.015 · Cited by 63
Safety out of control: dopamine and defence
Lloyd, K., & Dayan, P. (2016) · Behavioral and Brain Functions · doi:10.1186/s12993-016-0099-7 · Cited by 64
Role of Dopamine and D2 Dopamine Receptor in the Pathogenesis of Inflammatory Bowel Disease
Tolstanova, G. M., Deng, X., Ahluwalia, A., Paunovic, B., Prysiazhniuk, A., Остапченко, Л. І., Tarnawski, A. S., Sandor, Z., & Szabó, S. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3698-5 · Cited by 63
Thioridazine inhibits self-renewal in breast cancer cells via DRD2-dependent STAT3 inhibition, but induces a G1 arrest independent of DRD2
Tegowski, M., Fan, C., & Baldwin, A. S. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003719 · Cited by 63
Underlying Susceptibility to Eating Disorders and Drug Abuse: Genetic and Pharmacological Aspects of Dopamine D4 Receptors
Botticelli, L., Bonaventura, E. M. D., Bello, F. D., Giorgioni, G., Piergentili, A., Romano, A., Quaglia, W., Cifani, C., & Bonaventura, M. V. M. D. (2020) · Nutrients · doi:10.3390/nu12082288 · Cited by 63
Promising vulnerability markers of substance use and misuse: A review of human neurobehavioral studies
Lees, B., Garcia, A. M., Debenham, J., Kirkland, A. E., Bryant, B. E., Mewton, L. R., & Squeglia, L. M. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108500 · Cited by 64
Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and Disease
Kawahata, K., Finkelstein, D. I., & Fukunaga, K. (2024) · Receptors · doi:10.3390/receptors3020009 · Cited by 62
Membrane potential shapes regulation of dopamine transporter trafficking at the plasma membrane
Richardson, B. D., Saha, K., Krout, D., Cabrera, E. A., Felts, B., Henry, L. K., Swant, J., Zou, M., Newman, A. H., & Khoshbouei, H. (2016) · Nature Communications · doi:10.1038/ncomms10423 · Cited by 62
Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical Implications
Heckman, P. R. A., van Duinen, M. A., Bollen, E., Nishi, A., Wennogle, L. P., Blokland, A., & Prickaerts, J. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw030 · Cited by 63
Dopamine Increases CD14+CD16+ Monocyte Transmigration across the Blood Brain Barrier: Implications for Substance Abuse and HIV Neuropathogenesis
Calderon, T. M., Williams, D. W., Lopez, L., Eugenín, E. A., Cheney, L., Gaskill, P. J., Veenstra, M., Anastos, K., Morgello, S., & Berman, J. W. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9726-9 · Cited by 62
Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases
Schwartz, M. D., Canales, J. J., Zucchi, R., Espinoza, S., Sukhanov, I., & Gainetdinov, R. R. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1480723 · Cited by 62
Self-citation
Dopamine differentially modulates the size of projection neuron ensembles in the intact and dopamine-depleted striatum
Maltese, M., March, J. R., Bashaw, A. G., & Tritsch, N. X. (2021) · eLife · doi:10.7554/elife.68041 · Cited by 62
Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson’s disease patients
Krishnamoorthy, S., Rajan, R., Banerjee, M., Kumar, H., Sarma, G., Krishnan, S., Sarma, P. S., & Kishore, A. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.06.005 · Cited by 61
Flexible sensor for dopamine detection fabricated by the direct growth of α-Fe2O3 nanoparticles on carbon cloth
Mahesh, K. P. O., Shown, I., Chen, L., Chen, K., & Tai, Y. (2017) · Applied Surface Science · doi:10.1016/j.apsusc.2017.08.168 · Cited by 61
Cholinergic Projections to the Substantia Nigra Pars Reticulata Inhibit Dopamine Modulation of Basal Ganglia through the M4 Muscarinic Receptor
Moehle, M. S., Pancani, T., Byun, N. E., Yohn, S. E., Wilson, G. H., Dickerson, J. W., Remke, D. H., Xiang, Z., Niswender, C. M., Wess, J., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.12.008 · Cited by 61
D1 and D5 dopamine receptors participate on the consolidation of two different memories
Furini, C. R. G., Myskiw, J. C., Schmidt, B. E., Marcondes, L. A., & Izquierdo, I. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.06.027 · Cited by 60

Authors: Beaulieu, J.-M., & Gainetdinov, R. R.
Affiliations: Université Laval (CA)
Italian Institute of Technology (IT)
ORCID: Beaulieu, Jean-Martin
Gainetdinov, Raul R.
Venue: Pharmacological Reviews
Publisher: Elsevier BV
Published: 2011-03
Volume: 63
Issue: 1
Pages: 182-217
ISSN: 0031-6997 (ISSN-L)
DOI: 10.1124/pr.110.002642
OpenAlex: W2097744565
Cited by: 2,763
References: 409
Citations by year: 2026: 157 · 2025: 183 · 2024: 172 · 2023: 193 · 2022: 201 · 2021: 197 · 2020: 198 · 2019: 220 · 2018: 200 · 2017: 187 · 2016: 205 · 2015: 175 · 2014: 194 · 2013: 136 · 2012: 101
FWCI: 13.93
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Pharmacological Reviews (publishedVersion)
PubMed (publishedVersion)
Funders: Canadian Institutes of Health Research (NSA93798)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: dopamine receptors, dopamine D1/D5 receptors, G protein-coupled receptors, signal transduction, cAMP signaling, G protein-independent signaling, beta-arrestin, receptor desensitization, antiparkinsonian drugs, antipsychotic drugs
MeSH terms: Animals, Gene Expression Regulation, Humans, Ligands, Receptors, Dopamine, Signal Transduction, Dopamine Agonists, Dopamine Antagonists, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Physiology, Signaling, and Pharmacology of Dopamine Receptors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks